Serum Institute gets DCGI's nod to manufacture Sputnik V in India

2021-06-04 3

The Drugs Controller General of India (DCGI) granted permission to Serum Institute of India to manufacture Russian Covid-19 vaccine Sputnik V in India.

Free Traffic Exchange

Videos similaires

Serum Institute seeks DCGI nod to manufacture Covid-19 vaccine Sputnik V in India

COVID-19 Vaccine Update: Sputnik V To Undergo Trial In India, Dr Reddys Gets DCGI Approval, Serum Institute, Bharat Biotech To Start Intranasal Vaccine Trials

‘Serum Institute Seeks Permission To Manufacture Russian COVID19 Vaccine Sputnik-V’

‘Serum Institute Seeks Permission To Manufacture Russian COVID19 Vaccine Sputnik-V’

Serum Institute Of India’s Covovax Gets Emergency Use Listing Nod From World Health Organization

India's Covid-19 tally crosses 50 lakh-mark; Serum Institute gets nod to restart Oxford vaccine trial; more

COVID-19 Vaccine: Sputnik V To Undergo Trial In India, Serum Institute To Start Intranasal Trials

Corona Vaccine: India में तेजी से बनेगी Sputnik V, Serum Institute के साथ बड़ी डील | वनइंडिया हिंदी

Serum Institute of India ने DCGI से मांगी Sputnik V के निर्माण की इजाजत | Corona Vaccine

Oxford COVID-19 Vaccine ‘70% Effective’, Serum Institute Chief Says India Could Give Nod By Year-End

Web Analytics